KYLEENA® – Demonstrated ease of insertion
Investigator evaluation of insertion procedure2*
In an open-label, phase III pivotal trial, study investigators reported that they found the procedure easy to perform in:2
89.7%
of all women
84.3%
of nulliparous women
93.2%
of parous women
The study included 1,452 women aged 18–35 including 39.5% (574) nulliparous women.2
* Results from a multi-centre international, open-label, randomized clinical study for 3 years with an extension to 5 years in 1,452 women aged 18–35 evaluating the contraceptive efficacy of KYLEENA® (levonorgestrel-releasing intrauterine system [19.5 mg]).
